Kemnay Advisory Services’s AbbVie ABBV Stock Holding History

Kemnay Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$147K	Sell	677 -27	-4%	-$5.99K	0.02%	45
2025 Q4	$161K	Buy	+704	New	+$160K	0.02%	61
2021 Q4	–	Sell	-329	Closed	-$35K	–	36
2021 Q3	$35K	Hold	329	–	–	﹤0.01%	85
2021 Q2	$37K	Hold	329	–	–	﹤0.01%	89
2021 Q1	$36K	Sell	329 -7,998	-96%	-$855K	0.01%	84
2020 Q4	$892K	Buy	8,327 +7,998	+2,431%	+$769K	0.11%	56
2020 Q3	$29K	Hold	329	–	–	﹤0.01%	78
2020 Q2	$32K	Buy	+329	New	+$29K	﹤0.01%	81

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kemnay Advisory Services's ABBV Position: Q1 2026 in Review

Kemnay Advisory Services reduced its AbbVie (ABBV) stake by 3.8% in Q1 2026, selling an estimated $5.99K and leaving 677 shares worth $147K. The position accounts for 0.02% of the portfolio, ranked #45.

Kemnay Advisory Services first reported a position in ABBV in Q2 2020 and has held it in 8 quarters since. The position peaked at $892K in Q4 2020. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Kemnay Advisory Services held 677 shares of AbbVie worth $147K as of Q1 2026.
Kemnay Advisory Services sold 27 AbbVie shares in Q1 2026, an estimated $5.99K.
AbbVie made up 0.02% of Kemnay Advisory Services's portfolio in Q1 2026, its #45 holding.
Kemnay Advisory Services first reported a position in AbbVie in Q2 2020 and has held it in 8 quarters since.
Kemnay Advisory Services's AbbVie position peaked at $892K in Q4 2020.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.